Combination of kinase inhibitors and uses thereof
US9682141B2 · kind B2 · utility
4Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2012 |
| Grant date | Jun 20, 2017 |
| Priority date | — |
| Expiry date | Jun 8, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for a method for treating a disease condition associated with PI3-kinase a and/or a receptor tyrosine kinase (RTK) in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or an RTK in a subject. In yet another aspect, a method of inhibiting phosphorylation of Akt (S473) in a cell is set forth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.